A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti-Zika Virus Vaccine.
Nadine C SalischKathryn E StephensonKristi WilliamsFreek CoxLeslie van der FitsDirk HeerweghCarla TruyersMarrit N HabetsDiane G KanjilalRafael A LaroccaPeter AbbinkJinyan LiuLauren PeterCarlos FierroRafael A De La BarreraKayvon ModjarradRoland C ZahnJenny HendriksConor P CahillMaarten LeyssenMacaya DouoguihJohan van HoofHanneke SchuitemakerDan H BarouchPublished in: Annals of internal medicine (2021)
Janssen Vaccines and Infectious Diseases.